Sigue la actividad de operaciones con información privilegiada más reciente de Regencell Bioscience. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Regencell Bioscience.
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
Los expertos no han informado de compras ni ventas en los últimos 30 días.
No ha habido ninguna compra o venta de información privilegiada en los últimos 90 días.
Aug 29, 2017 | DIRECTOR | 25.00K | $14.76 | $369.00K | BUY | 24.52% | 126.94K | Aug 29 | ||
Aug 28, 2017 | DIRECTOR | 10.00K | $14.87 | $148.70K | BUY | 6.87% | 155.57K | Aug 25 | ||
Aug 24, 2017 | EVP, CFO AND TREASURER | 7.50K | $14.04 | $105.30K | BUY | 3.38% | 229.57K | Aug 24 | ||
Mar 10, 2017 | EVP, GENERAL COUNSEL, SEC. | -20.23K | $22.50 | -$455.24K | SELL | -8.69% | 212.72K | Mar 09 | ||
Mar 10, 2017 | PRESIDENT AND COO | -26.05K | $22.15 | -$577.01K | SELL | -27.98% | 67.05K | Mar 09 | ||
Nov 23, 2016 | 10% OWNER | -13.00M | $22.95 | -$298.35M | SELL | -100.00% | 0.00 | Nov 23 | ||
Sep 08, 2016 | PRESIDENT AND COO | -30.77K | $21.75 | -$669.14K | SELL | -29.32% | 74.15K | Sep 07 | ||
Aug 08, 2016 | 10% OWNER | -13.00M | $21.60 | -$280.80M | SELL | -91.81% | 1.16M | Aug 08 | ||
Jun 29, 2016 | EVP, GENERAL COUNSEL, SEC. | -49.02K | $21.51 | -$1.05M | SELL | -18.29% | 219.03K | Jun 29 | ||
Jun 17, 2016 | PRESIDENT AND COO | -25.00K | $20.28 | -$507.00K | SELL | -19.24% | 104.92K | Jun 15 | ||
Mar 16, 2016 | CEO | -103.20K | $21.11 | -$2.18M | SELL | -14.92% | 588.40K | Mar 14 - Mar 15 | ||
May 20, 2015 | PRESIDENT AND COO | -19.00K | $21.40 | -$406.60K | SELL | -14.76% | 109.72K | May 19 | ||
Apr 13, 2015 | DIRECTOR | 88.14 | $22.54 | $1.99K | BUY | 0.17% | 52.84K | Mar 13 | ||
Feb 19, 2015 | DIRECTOR | -58.48K | $23.37 | -$1.37M | SELL | -91.77% | 5.24K | Feb 18 |
Explora operaciones con información privilegiada sobre todos los valores.